BioSpace News Archive

Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced that Diane Wilfong has been appointed to the Company’s board of directors.

AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that the Cystic Fibrosis Foundation (CFF) Data Safety Monitoring Board (DSMB) has completed its review of the Company’s final results of the Phase 2 OPTION trial and has found no safety concerns for MS1819-SD.

The Muscular Dystrophy Association’s (MDA) New York Muscle Team is hosting its 23rd annual Gala on Tuesday, November 19, 2019 from 6 to 10 p.m. at Cipriani Wall Street (55 Wall Street, New York, NY)

Cerebral palsy is the most common childhood physical disability in the United States, affecting more than 760,000 children and adults nationally.

An Outstanding Public Servant, A Dedicated Humanitarian, A Fierce Social Justice Advocate, and A Great Friend

Among patients with multiple myeloma, African Americans and Hispanics start treatment with a novel therapy significantly later than white patients, according to a new study published today in Blood Advances

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will report financial results for the third quarter 2019 after market close on Thursday, November 7, 2019.

Medtronic plc, the global leader in medical technology, announced the launch of GI Genius™ intelligent endoscopy module at UEG Week in Barcelona, Spain.

Oxford-based start-up Ultromics has announced the appointment of Amir Hasan as Chief Commercial Officer. Amir previously worked as Global Head of Cardiology Informatics at Philips.

Neurobiologist with ten years’ Autism Spectrum Disorder experience takes on the lead research strategy role at the Swiss biotech